AstraZeneca to Pay Daiichi Sankyo Up to $6.9 Billion in Cancer Drug Deal

AstraZeneca to Pay Daiichi Sankyo Up to $6.9 Billion in Cancer Drug Deal

Assessment

Interactive Video

Business, Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

The video discusses the collaboration between AstraZeneca and Daiichi Sankyo to develop and market the cancer drug Trastuzumab. It highlights the strategic goals of both companies, recent major cancer drug deals, and AstraZeneca's funding strategy. The video also explores the market potential for cancer treatments, particularly in regions with high demand like Japan and China.

Read more

2 questions

Show all answers

1.

OPEN ENDED QUESTION

3 mins • 1 pt

What challenges are faced by the Bristol Myers Squibb and Celgene deal?

Evaluate responses using AI:

OFF

2.

OPEN ENDED QUESTION

3 mins • 1 pt

Why is there a high demand for cancer treatments in markets like Japan and China?

Evaluate responses using AI:

OFF